211 related articles for article (PubMed ID: 19018715)
1. Association studies of the BDNF and the NTRK2 gene polymorphisms with prophylactic lithium response in bipolar patients.
Dmitrzak-Weglarz M; Rybakowski JK; Suwalska A; Skibinska M; Leszczynska-Rodziewicz A; Szczepankiewicz A; Hauser J
Pharmacogenomics; 2008 Nov; 9(11):1595-603. PubMed ID: 19018715
[TBL] [Abstract][Full Text] [Related]
2. The association study of three FYN polymorphisms with prophylactic lithium response in bipolar patients.
Szczepankiewicz A; Skibinska M; Suwalska A; Hauser J; Rybakowski JK
Hum Psychopharmacol; 2009 Jun; 24(4):287-91. PubMed ID: 19330793
[TBL] [Abstract][Full Text] [Related]
3. Clinical and pathogenic aspects of candidate genes for lithium prophylactic efficacy.
Rybakowski JK; Czerski P; Dmitrzak-Weglarz M; Kliwicki S; Leszczynska-Rodziewicz A; Permoda-Osip A; Skibinska M; Suwalska A; Szczepankiewicz A; Hauser J
J Psychopharmacol; 2012 Mar; 26(3):368-73. PubMed ID: 21890592
[TBL] [Abstract][Full Text] [Related]
4. Lithium response and Val66Met polymorphism of the brain-derived neurotrophic factor gene in Japanese patients with bipolar disorder.
Masui T; Hashimoto R; Kusumi I; Suzuki K; Tanaka T; Nakagawa S; Suzuki T; Iwata N; Ozaki N; Kato T; Kunugi H; Koyama T
Psychiatr Genet; 2006 Apr; 16(2):49-50. PubMed ID: 16538178
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic lithium response and polymorphism of the brain-derived neurotrophic factor gene.
Rybakowski JK; Suwalska A; Skibinska M; Szczepankiewicz A; Leszczynska-Rodziewicz A; Permoda A; Czerski PM; Hauser J
Pharmacopsychiatry; 2005 Jul; 38(4):166-70. PubMed ID: 16025419
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism of circadian clock genes and prophylactic lithium response.
Rybakowski JK; Dmitrzak-Weglar M; Kliwicki S; Hauser J
Bipolar Disord; 2014 Mar; 16(2):151-8. PubMed ID: 24636202
[TBL] [Abstract][Full Text] [Related]
7. Response to lithium prophylaxis: interaction between serotonin transporter and BDNF genes.
Rybakowski JK; Suwalska A; Skibinska M; Dmitrzak-Weglarz M; Leszczynska-Rodziewicz A; Hauser J
Am J Med Genet B Neuropsychiatr Genet; 2007 Sep; 144B(6):820-3. PubMed ID: 17373693
[TBL] [Abstract][Full Text] [Related]
8. [Predictors of prophylactic response to lithium].
Rohayem J; Baylé JF; Richa S
Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
[TBL] [Abstract][Full Text] [Related]
9. Gene-gene interactions of the brain-derived neurotrophic-factor and neurotrophic tyrosine kinase receptor 2 genes in geriatric depression.
Lin E; Hong CJ; Hwang JP; Liou YJ; Yang CH; Cheng D; Tsai SJ
Rejuvenation Res; 2009 Dec; 12(6):387-93. PubMed ID: 20014955
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid receptor polymorphism is associated with lithium response in bipolar patients.
Szczepankiewicz A; Rybakowski JK; Suwalska A; Hauser J
Neuro Endocrinol Lett; 2011; 32(4):545-51. PubMed ID: 21876507
[TBL] [Abstract][Full Text] [Related]
11. The interaction of BDNF and NTRK2 gene increases the susceptibility of paranoid schizophrenia.
Lin Z; Su Y; Zhang C; Xing M; Ding W; Liao L; Guan Y; Li Z; Cui D
PLoS One; 2013; 8(9):e74264. PubMed ID: 24069289
[TBL] [Abstract][Full Text] [Related]
12. Neurotrophic tyrosine kinase receptor type 2 (NTRK2) gene associated with treatment response to mood stabilizers in patients with bipolar I disorder.
Wang Z; Fan J; Gao K; Li Z; Yi Z; Wang L; Huang J; Yuan C; Hong W; Yu S; Fang Y
J Mol Neurosci; 2013 Jun; 50(2):305-10. PubMed ID: 23315174
[TBL] [Abstract][Full Text] [Related]
13. [Long-term lithium prophylaxis in the bipolar affective disorder].
Suwalska A; Chłopocka-Woźniak M; Rybakowski J
Psychiatr Pol; 2002; 36(6 Suppl):63-9. PubMed ID: 12647423
[TBL] [Abstract][Full Text] [Related]
14. Association study of the INPP1, 5HTT, BDNF, AP-2beta and GSK-3beta GENE variants and restrospectively scored response to lithium prophylaxis in bipolar disorder.
Michelon L; Meira-Lima I; Cordeiro Q; Miguita K; Breen G; Collier D; Vallada H
Neurosci Lett; 2006 Aug; 403(3):288-93. PubMed ID: 16787706
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D1 receptor gene polymorphism is associated with prophylactic lithium response in bipolar disorder.
Rybakowski JK; Dmitrzak-Weglarz M; Suwalska A; Leszczynska-Rodziewicz A; Hauser J
Pharmacopsychiatry; 2009 Jan; 42(1):20-2. PubMed ID: 19153942
[TBL] [Abstract][Full Text] [Related]
16. Extensive genotyping of the BDNF and NTRK2 genes define protective haplotypes against obsessive-compulsive disorder.
Alonso P; Gratacòs M; Menchón JM; Saiz-Ruiz J; Segalàs C; Baca-García E; Labad J; Fernández-Piqueras J; Real E; Vaquero C; Pérez M; Dolengevich H; González JR; Bayés M; de Cid R; Vallejo J; Estivill X
Biol Psychiatry; 2008 Mar; 63(6):619-28. PubMed ID: 17884018
[TBL] [Abstract][Full Text] [Related]
17. Association studies of 5-HT2A and 5-HT2C serotonin receptor gene polymorphisms with prophylactic lithium response in bipolar patients.
Dmitrzak-Weglarz M; Rybakowski JK; Suwalska A; Słopień A; Czerski PM; Leszczyńska-Rodziewicz A; Hauser J
Pharmacol Rep; 2005; 57(6):761-5. PubMed ID: 16382194
[TBL] [Abstract][Full Text] [Related]
18. Association study of
Paul P; Nadella RK; Sen S; Ithal D; Mahadevan J; Reddy Y C J; Jain S; Purushottam M; Viswanath B
J Psychopharmacol; 2021 Dec; 35(12):1510-1516. PubMed ID: 34311608
[TBL] [Abstract][Full Text] [Related]
19. A possible association between the -116C/G single nucleotide polymorphism of the XBP1 gene and lithium prophylaxis in bipolar disorder.
Masui T; Hashimoto R; Kusumi I; Suzuki K; Tanaka T; Nakagawa S; Kunugi H; Koyama T
Int J Neuropsychopharmacol; 2006 Feb; 9(1):83-8. PubMed ID: 15927087
[TBL] [Abstract][Full Text] [Related]
20. No association between the PREP gene and lithium responsive bipolar disorder.
Mamdani F; Sequeira A; Alda M; Grof P; Rouleau G; Turecki G
BMC Psychiatry; 2007 Feb; 7():9. PubMed ID: 17324276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
